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Recommendations NICE recommendations are based on systematic reviews of best available evidence. When minimal evidence is available, recommendations are based on the guideline development group's opinion of what constitutes good practice. Evidence levels for the recommendations are in the longer version of this article on bmj.com.
Holistic assessment and management of symptomatic osteoarthritis
Assess the effect of osteoarthritis on the individual's function, quality of life, occupation, mood, relationships, and leisure activities. Provide periodic review tailored to an individual's needs. Formulate a management plan in partnership with the person with osteoarthritis, taking into consideration comorbidities that compound the effect of osteoarthritis.
Communicate the risks and benefits of treatment options in ways that can be understood.
Core treatments
Provide advice on the following to all people with symptomatic osteoarthritis: Access to appropriate information, oral and written, to enhance understanding of the condition and to counter misconceptions (such as osteoarthritis is inevitably progressive and cannot be treated). Other treatments can be used as adjuncts to these core treatments (see figure) , and a person with osteoarthritis may use several of these treatments. Some treatments will be useful only for certain joints.
Adjunct non-pharmacological treatments
Agree on self management strategies with the person with osteoarthritis, emphasising the recommended core treatments, especially exercise. Target positive behavioural changes as appropriate-such as exercise, weight loss, use of suitable footwear (that is, with shock absorbing properties) and pacing (avoiding "peaks" and "troughs" of activities). Consider other therapies, such as: -Local heat or cold applications -Manipulation and stretching, particularly for osteoarthritis of the hip -Transcutaneous electrical nerve stimulation (TENS) -Assessment for bracing, joint supports, or insoles in those with biomechanical joint pain or instability -Assistive devices (for example, walking sticks and tap turners) for those who have specific problems with activities of daily living. Expert advice may be sought, for example, from occupational therapists or disability equipment assessment centres. Electroacupuncture should not be used. Insufficient evidence exists (despite RCTs and cost effectiveness analysis) to make a firm recommendation on acupuncture. The use of glucosamine and chondroitin products is not recommended.
Adjunct pharmacological treatments
Consider risks and benefits of pharmacological treatments, particularly in elderly people and those with comorbidities.
This is one of a series of BMJ summaries of new guidelines, which are based on the best available evidence; they will highlight important recommendations for clinical practice, especially where uncertainty or controversy exists. Further information about the guidance, a list of members of the guideline development group, and the supporting evidence statements are in the version on bmj.com. Rubefacients and intra-articular hyaluronan injections are not recommended for the treatment of osteoarthritis.
Referral for surgical interventions
Referral for arthroscopic lavage and debridement should not be routinely offered as part of treatment for osteoarthritis, unless the person has knee osteoarthritis with a clear history of mechanical locking (therefore not for reasons such as gelling (stiffness and pain associated with prolonged immobility) "giving way," or x ray evidence of loose bodies-currently common inappropriate reasons for referral). Before referring a patient for consideration of joint surgery, ensure that he or she has been offered at least the core treatment options. Consider referral for joint replacement surgery for people with osteoarthritis who have joint symptoms (pain, stiffness, and reduced function) that substantially affect their quality of life and are refractory to non-surgical treatment. Referral should be made before there is prolonged and established functional limitation and severe pain. Patient specific factors (including age, sex, smoking, obesity, and comorbidities) should not be barriers to referral for joint replacement surgery. Base decisions about referral thresholds on discussions between patient representatives, referring clinicians, and surgeons, rather than on current scoring tools for prioritisation.
Overcoming barriers Improved understanding, among healthcare professionals and people with osteoarthritis, of the range of treatments available will reduce misconceptions and negativity about osteoarthritis and its treatment. Emphasising the recommended core treatments, other simple, non-pharmacological treatments, and relatively safe agents such as paracetamol and topical NSAIDs will help to reduce drug toxicity and the focus on pharmacological treatments.
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